Results 51 to 60 of about 49,884 (215)

Single-Dose Vaccination of Recombinant Chimeric Newcastle Disease Virus (NDV) LaSota Vaccine Strain Expressing Infectious Bursal Disease Virus (IBDV) VP2 Gene Provides Full Protection against Genotype VII NDV and IBDV Challenge

open access: yesVaccines, 2021
Newcastle disease virus (NDV) and infectious bursal disease virus (IBDV) are the two most important and widespread viruses causing huge economic losses in the global poultry industry.
Qilong Qiao   +11 more
doaj   +1 more source

ASIP Promoter Variants Predict the Sesame Coat Color in Shiba Inu Dogs

open access: yesVeterinary Sciences, 2022
Animals exhibit a wide variety of genetically determined coat colors and pigmentation patterns that serve important roles in adaptation and communication.
Stepan N. Belyakin   +4 more
doaj   +1 more source

The relative expressed intensity of VP2 protein.

open access: yes, 2015
(A) BV-S-ITRs-VP2; (B) BV-S-ITRs-VP2/4/3; (C) β-actin control. The VP2 protein intensity of recombinant baculovirus BV-VP2 and BV-VP2/4/3 was analyzed and the relative amount of VP2 protein was quantified.
Qi An (331241)   +4 more
core   +1 more source

Construction of the baculovirus transfer vectors pS-ITRs-VP2 and pS-ITRs-VP2/4/3.

open access: yes, 2015
Plasmids pTZF-VP2 and pA-8 were used as templates, vp2 and vp2/4/3 target genes were amplified and separately inserted into vector pS-CMV according to the respective restriction sites Apa I/Kpn I to construct the baculovirus transfer vectors pS-ITRs-VP2 ...
Qi An (331241)   +4 more
core   +1 more source

Evolutionary and genetic analysis of the VP2 gene of canine parvovirus

open access: yesBMC Genomics, 2017
Canine parvovirus (CPV) type 2 emerged in 1978 in the USA and quickly spread among dog populations all over the world with high morbidity. Although CPV is a DNA virus, its genomic substitution rate is similar to some RNA viruses. Therefore, it is important to trace the evolution of CPV to monitor the appearance of mutations that might affect vaccine ...
Gairu Li   +7 more
openaire   +3 more sources

Immunogenicity of VLP-VP2 in mice (determination of antibody titers of VLP-VP2 in mice).

open access: yes, 2014
Immunogenicity of VLP-VP2 in mice (determination of antibody titers of VLP-VP2 in mice).
Yu-wei Gao (510434)   +13 more
core   +1 more source

Secreted Nonstructural Protein 3 is a Pathogenic Determinant of Orbivirus

open access: yesAdvanced Science, EarlyView.
This study uncovers a conserved PIP2‐dependent secretory pathway of orbivirus NS3 that induces vascular leakage. Pharmacological disruption of PIP2‐NS3 interaction significantly reduces viral pathogenicity and provides protective efficacy in murine models, establishing PIP2‐mediated NS3 secretion as both a key virulence determinant and a promising ...
Junyong Guan   +11 more
wiley   +1 more source

Expression and purification of CPV-VP2 proteins.

open access: yes, 2015
Protein detection using SDS-PAGE (a): lane 1, His-Sumo-VP2 (85 kDa); lane 2, VP2 protein (65 kDa). Identification of proteins using Western blot (b): lane 1, His-Sumo-VP2; lane 2, VP2 protein.
Ye Jin (286793)   +7 more
core   +1 more source

Targeting Endogenous Lipophagy: A Novel Strategy to Enhance MSC Osteogenesis and Mineralization for Senile Osteoporosis Therapy

open access: yesAdvanced Science, EarlyView.
Schematic representation of the role of lipophagy in bone mesenchymal stem cells(MSCs). In healthy MSCs, functional lipophagy efficiently degrades lipid droplets to support oxidative phosphorylation and cellular energy production, thereby facilitating osteogenic differentiation and matrix mineralization.
Chaoqiang Chen   +8 more
wiley   +1 more source

Effect of VP2 myristoylation on transduction.

open access: yes, 2013
(A) Purified MCV pseudoviruses made with WT VP2 or Gly2-mutated VP2 (G2F, G2S, and G2V) were analyzed by SDS-PAGE and SYPRO Ruby protein stain. (B) The infectivity of MCV pseudoviruses containing WT VP2 or Gly2-mutated VP2 was determined in 293TT cells ...
Christopher B. Buck (121726)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy